Correlation Between Moberg Pharma and Mendus AB
Can any of the company-specific risk be diversified away by investing in both Moberg Pharma and Mendus AB at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Moberg Pharma and Mendus AB into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Moberg Pharma AB and Mendus AB, you can compare the effects of market volatilities on Moberg Pharma and Mendus AB and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Moberg Pharma with a short position of Mendus AB. Check out your portfolio center. Please also check ongoing floating volatility patterns of Moberg Pharma and Mendus AB.
Diversification Opportunities for Moberg Pharma and Mendus AB
-0.02 | Correlation Coefficient |
Good diversification
The 3 months correlation between Moberg and Mendus is -0.02. Overlapping area represents the amount of risk that can be diversified away by holding Moberg Pharma AB and Mendus AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Mendus AB and Moberg Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Moberg Pharma AB are associated (or correlated) with Mendus AB. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Mendus AB has no effect on the direction of Moberg Pharma i.e., Moberg Pharma and Mendus AB go up and down completely randomly.
Pair Corralation between Moberg Pharma and Mendus AB
Assuming the 90 days trading horizon Moberg Pharma AB is expected to generate 1.23 times more return on investment than Mendus AB. However, Moberg Pharma is 1.23 times more volatile than Mendus AB. It trades about 0.08 of its potential returns per unit of risk. Mendus AB is currently generating about 0.04 per unit of risk. If you would invest 825.00 in Moberg Pharma AB on September 1, 2024 and sell it today you would earn a total of 960.00 from holding Moberg Pharma AB or generate 116.36% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Moberg Pharma AB vs. Mendus AB
Performance |
| Timeline |
| Moberg Pharma AB |
| Mendus AB |
Moberg Pharma and Mendus AB Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Moberg Pharma and Mendus AB
The main advantage of trading using opposite Moberg Pharma and Mendus AB positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Moberg Pharma position performs unexpectedly, Mendus AB can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Mendus AB will offset losses from the drop in Mendus AB's long position.| Moberg Pharma vs. Swedencare publ AB | Moberg Pharma vs. Enzymatica publ AB | Moberg Pharma vs. KABE Group AB | Moberg Pharma vs. IAR Systems Group |
| Mendus AB vs. Cantargia AB | Mendus AB vs. BioInvent International AB | Mendus AB vs. Alligator Bioscience AB | Mendus AB vs. Moberg Pharma AB |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.
Other Complementary Tools
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |